Health-related Quality of Life and Quality-Adjusted Progression Free Survival for Carfilzomib and Dexamethasone Maintenance Following Salvage Autologous Stem-Cell Transplantation in Patients with Multiple Myeloma: a Randomized Phase 2 Trial by the Nordic Myeloma Study Group

JOURNAL OF PATIENT-REPORTED OUTCOMES（2024）

引用 0|浏览21

暂无评分

关键词

Randomized clinical trial,Multiple myeloma,Health-related quality of life,Carfilzomib

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要